- Home
- KARO vs RAPT Comparison
KARO vs RAPT Comparison
Compare KARO & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KARO | RAPT |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KARO | RAPT |
|---|---|---|
| Price | $48.55 | $57.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $58.25 | $56.22 |
| AVG Volume (30 Days) | 53.0K | ★ 6.2M |
| Earning Date | 01-20-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.57% | N/A |
| EPS Growth | ★ 16.09 | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $306,597,294.00 | N/A |
| Revenue This Year | $22.17 | N/A |
| Revenue Next Year | $16.74 | N/A |
| P/E Ratio | $25.13 | ★ N/A |
| Revenue Growth | ★ 18.35 | N/A |
| 52 Week Low | $35.88 | $5.67 |
| 52 Week High | $63.36 | $57.86 |
Technical Indicators
Market Signals| Indicator | KARO | RAPT |
|---|---|---|
| Relative Strength Index (RSI) | 53.12 | 79.21 |
| Support Level | $46.82 | $57.61 |
| Resistance Level | $52.60 | $57.86 |
| Average True Range (ATR) | 2.17 | 0.12 |
| MACD | -0.07 | -0.72 |
| Stochastic Oscillator | 41.18 | 74.14 |
Price Performance
Historical ComparisonAbout KARO Karooooo Ltd.
Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.